A novel small molecule compound VCP979 improves ventricular remodeling in murine models of myocardial ischemia/reperfusion injury-Reference-Cited by-同舟云学术

A novel small molecule compound VCP979 improves ventricular remodeling in murine models of myocardial ischemia/reperfusion injury

Published:2019-11-27 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Liu Jing¹,Meng Qingshu²,Liang Xiaoting²,Zhuang Rulin²,Yuan Dongsheng²,Ge Xinyu²,Cao Hao³,Lin Fang²,Gong Xin⁴,Fan Huimin²,Wang Binghui⁵,Zhou Xiaohui²,Liu Zhongmin¹

Affiliation:

1. Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China

2. Research Center for Translational Medicine, Shanghai 200120, P.R. China

3. Department of Cardiovascular and Thoracic Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China

4. Department of Heart Failure, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China

5. Biomarker Discovery Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with preserved ejection fraction: The role of inflammation;European Journal of Pharmacology;2024-10

2. Novel small-molecule compound VCP979 attenuates renal fibrosis in male rats with unilateral ureteral obstruction;Experimental Biology and Medicine;2023-01-30

3. Evaluation of the Advantages of Myocardial Blood Flow Index in the Diagnosis of Chronic Obstructive Coronary Artery Disease Versus Coronary Computed Tomography Angiography: A Feasibility Study;Iranian Journal of Radiology;2022-11-14

4. Reducing White Adipose Tissue Browning Using p38α MAPK Inhibitors Ameliorates Cancer-Associated Cachexia as Assessed by Magnetic Resonance Imaging;Nutrients;2022-07-22

5. Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4+ T cells into the infarcted heart via CCL5/CCR5 signaling;Stem Cell Research & Therapy;2022-06-11